Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Thrombosis
•
Hematology
•
Pediatric Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
Are there any circumstances where you would consider bridging for patients on DOACs?
What if the surgery is within 30 days of the blood clot?
Related Questions
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?
Does your evaluation of a young person with spontaneous upper extremity DVT vary as compared to lower extremity DVT?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
Would you anticoagulate a patient with splenic infarctions in the setting of CMV viremia?
How do you manage hemophilia A carriers with no history of bleeding complications but with mildly low factor VIII activity (6-40%)?
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
How would you counsel a female to male transgender patient regarding VTE risk with testosterone therapy, who has additional mild-moderate risk factors for thrombosis?
How would you manage a chronic thrombosis of the internal jugular vein?